Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Third Harmonic Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for THRD.
You can purchase shares of Third Harmonic Bio (NASDAQ:THRD) through any online brokerage.
Other companies in Third Harmonic Bio’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Bioage Labs (NASDAQ:BIOA), Rapport Therapeutics (NASDAQ:RAPP), Neumora Therapeutics (NASDAQ:NMRA) and Alumis (NASDAQ:ALMS).
Third Harmonic Bio has a consensus price target of $10.53.
The stock price for Third Harmonic Bio (NASDAQ: THRD) is $3.44 last updated March 3, 2025 at 7:41 PM EST.
A quarterly cash dividend of 0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on August 15, 2014 to stockholders of record on August 6, 2014.
Third Harmonic Bio’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Third Harmonic Bio.
Third Harmonic Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.